Timing of final oncologist visit and systemic treatment use near the end of life in pretreated patients with metastatic triple-negative breast cancer: a multinational cohort study [0.03%]
转移性三阴性乳腺癌经治患者的末次肿瘤科就诊时间及生命晚期全身治疗使用情况的多国队列研究
Justyna Żubrowska,Małgorzata Pieniążek,Anna Polakiewicz-Gilowska et al.
Justyna Żubrowska et al.
Background: In heavily pretreated patients with metastatic triple-negative breast cancer (mTNBC), further systemic therapy offers limited benefit and increased toxicity. Recognizing the end-of-life (EOL) phase in time hel...
The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy [0.03%]
蒽环类药物化疗对乳腺癌患者疲劳纵向轨迹影响的探索性研究
Anneke Kastelein,Laura Kervezee,Dieuwke R Mink van der Molen et al.
Anneke Kastelein et al.
Background: Cancer-related fatigue is a common and profound side effect of cancer treatment. The specific impacts of different classes of chemotherapy remains understudied. This study aimed to compare the trajectory of fa...
Impact of the interruption of tamoxifen for pregnancy on the recurrence and survival outcomes among young women with breast cancer [0.03%]
他莫昔芬治疗期间因怀孕中断对其年轻乳腺癌患者复发和生存预后影响的研究
Chihwan David Cha,Somin Jeon,Jihyun Keum et al.
Chihwan David Cha et al.
Background: Young survivors of breast cancer often consider pregnancy after completing or interrupting endocrine therapy. However, concerns remain regarding the safety of tamoxifen interruption for pregnancy and its impac...
The efficacy of intra-operative injection of [99mTc] labelled colloidal nanoparticles for sentinel lymph nodes identification in breast cancer [0.03%]
放射性纳米颗粒用于乳腺癌手术中定位哨点淋巴结的可行性研究
Or Barkai,Itamar Ashkenazi,Aviad Hoffman
Or Barkai
Background: Sentinel lymph node (SLN) biopsy is a critical component of axillary staging in breast cancer management. Traditionally, Technetium-99m (Tc-99m) labelled colloidal nanoparticles is injected preoperatively in t...
Guiding treatment decisions in early breast cancer: A model-based comparison of the OncotypeDX and MammaPrint tests [0.03%]
早期乳腺癌治疗决策导向：基于模型的OncoType DX和MammaPrint检测比较研究
Frank Doornkamp,Liesbeth C de Wreede,Elfi Verheul et al.
Frank Doornkamp et al.
Introduction: Genomic tests may improve chemotherapy allocation in early-stage breast cancer beyond traditional clinical factors. We compared the clinical usefulness of two multi-genomic tests, MammaPrint and OncotypeDX, ...
Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer [0.03%]
绝经前患者HER2阳性、激素受体阳性乳腺癌辅助内分泌治疗的优化
Carmine Valenza,Ann H Partridge,Meredith M Regan
Carmine Valenza
Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapy [0.03%]
乳房成分与放射治疗后的乳腺副作用之间存在联系
Tanwiwat Jaikuna,Fiona Wilson,Carmel Anandadas et al.
Tanwiwat Jaikuna et al.
Objective: Breast comprises different tissues with potentially different dose responses to radiation therapy (RT). This study investigates the correlation between RT dose, breast composition, and side effects from breast ...
Standardized patient coaching improves therapy persistence in patients with hormone receptor-positive, HER2-negative advanced/metastatic breast cancer treated with abemaciclib [0.03%]
标准患者指导可提高激素受体阳性、HER2阴性晚期/转移性乳腺癌患者使用阿贝西利治疗的依从性
Manfred Welslau,Peter A Fasching,Nicole Semmler-Lins et al.
Manfred Welslau et al.
Introduction: Therapy adherence is critical, particularly for patients with breast cancer undergoing oral endocrine therapies. The use of combination regimes, such as CDK4/6 inhibitors, has introduced additional side effe...
Short commentaries on data published by Yono et al. on avoiding breast cancer-related arm lymphedema with the lymphatic microsurgical preventive healing approach [0.03%]
关于Yono等人发表的有关利用淋巴显微外科预防性治疗避免乳腺癌相关上肢淋巴水肿的数据的短评论
Da Qian,Xuli Meng,Min Jia
Da Qian
Lymphatic microsurgical preventive healing approach (LyMPHA) is being adopted to prevent arm lymphedema after axillary lymph node dissection (ALND), but open questions remain over selection bias, non-standardized endpoints and variable surg...
Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years [0.03%]
年轻成人转移性乳腺癌的基因组景观：一项关于20-40岁女性的研究
Ernest Diab,Cyril Roussel-Simonin,Federica Giugliano et al.
Ernest Diab et al.
Introduction: Breast cancer in young adults (YA) aged 20-40 years has distinct clinical and biological traits compared with older patients. This study evaluated the genomic landscape of metastatic breast cancers (MBC) amo...